Key Statistics for QCOR
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (USD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for QCOR
- Net Income (M/USD)
Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
More Company Profile & Key Executives for QCOR
|Don M BaileyPresident/CEO||Stephen L Cartt "Steve"Chief Operating Officer|
|David YoungChief Scientific Officer||Michael H Mulroy "Mike"Exec VP/CFO/Secy/Gen Cnsl|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.